Modulation of PICALM levels perturbs cellular cholesterol homeostasis

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Mercer, Jacob L ^a   Argus, Joseph P ^b   Crabtree, Donna M ^a   Keenan, Melissa M ^a,c   Wilks, Moses Q ^d   Chi, Jen Tsan Ashley ^a,c   Bensinger, Steven J ^b   Lavau, Catherine P ^a   Wechsler, Daniel S ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN ASSEMBLY PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYL INOSITOL CLATHRIN ASSEMBLY LYMPHOID MYELOID PROTEIN; SNARE PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG; CHOLESTEROL; PICALM PROTEIN, HUMAN; PICALM PROTEIN, MOUSE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL METABOLISM; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EMBRYO; ENDOCYTOSIS; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTERNALIZATION; MASS FRAGMENTOGRAPHY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL LINE; GENE INACTIVATION; GENETICS; HOMEOSTASIS; METABOLISM; RNA INTERFERENCE;

ANIMALS; BIOSYNTHETIC PATHWAYS; CELL LINE; CHOLESTEROL; GENE EXPRESSION; GENE KNOCKOUT TECHNIQUES; HOMEOSTASIS; HUMANS; MICE; MONOMERIC CLATHRIN ASSEMBLY PROTEINS; ORGAN SPECIFICITY; PROTEIN TRANSPORT; RECEPTORS, LDL; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84937019921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129776     Document Type: Article

References (81)

1. Legendre-Guillemin V, Wasiak S, Hussain NK, Angers A, McPherson PS. ENTH/ANTH proteins and clathrin-mediated membrane budding. Journal of cell science. 2004; 117(Pt 1):9-18. Epub 2003/12/06. doi: 10.1242/jcs.00928 PMID: 14657269.
2. Meyerholz A, Hinrichsen L, Groos S, Esk PC, Brandes G, Ungewickell EJ. Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation. Traffic. 2005; 6(12):1225-34. Epub 2005/11/03. doi: 10.1111/j.1600-0854.2005.00355.x PMID: 16262731.
3. Tebar F, Bohlander SK, Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Molecular biology of the cell. 1999; 10(8):2687-702. Epub 1999/08/06. PMID: 10436022; PubMed Central PMCID: PMC25500.
4. Ford MG, Pearse BM, Higgins MK, Vallis Y, Owen DJ, Gibson A, et al. Simultaneous binding of PtdIns (4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science. 2001; 291 (5506):1051-5. Epub 2001/02/13. doi: 10.1126/science.291.5506.1051 PMID: 11161218.
5. Scotland PB, Heath JL, Conway AE, Porter NB, Armstrong MB, Walker JA, et al. The PICALM Protein Plays a Key Role in Iron Homeostasis and Cell Proliferation. PloS one. 2012; 7(8):e44252. Epub 2012/09/07. doi: 10.1371/journal.pone.0044252 PMID: 22952941; PubMed Central PMCID: PMC3431333.
6. Huang F, Khvorova A, Marshall W, Sorkin A. Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. The Journal of biological chemistry. 2004; 279(16):16657-61. Epub 2004/02/27. doi: 10.1074/jbc.C400046200 PMID: 14985334.
7. Suzuki M, Tanaka H, Tanimura A, Tanabe K, Oe N, Rai S, et al. The clathrin assembly protein PICALM is required for erythroid maturation and transferrin internalization in mice. PloS one. 2012; 7(2):e31854. Epub 2012/03/01. doi: 10.1371/journal.pone.0031854 PMID: 22363754; PubMed Central PMCID: PMC3283694.
8. Sahlender DA, Kozik P, Miller SE, Peden AA, Robinson MS. Uncoupling the functions of CALM in VAMP sorting and clathrin-coated pit formation. PloS one. 2013; 8(5):e64514. Epub 2013/06/07. doi: 10.1371/journal.pone.0064514 PMID: 23741335; PubMed Central PMCID: PMC3669311.
9. Zhang B, Koh YH, Beckstead RB, Budnik V, Ganetzky B, Bellen HJ. Synaptic vesicle size and number are regulated by a clathrin adaptor protein required for endocytosis. Neuron. 1998; 21(6):1465-75. Epub 1999/01/12. PMID: 9883738.
10. Harel A, Wu F, Mattson MP, Morris CM, Yao PJ. Evidence for CALM in directing VAMP2 trafficking. Traffic. 2008; 9(3):417-29. Epub 2008/01/10. doi: 10.1111/j.1600-0854.2007.00694.x PMID: 18182011.
11. Koo SJ, Markovic S, Puchkov D, Mahrenholz CC, Beceren-Braun F, Maritzen T, et al. SNARE motif-mediated sorting of synaptobrevin by the endocytic adaptors clathrin assembly lymphoid myeloid leukemia (CALM) and AP180 at synapses. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(33):13540-5. Epub 2011/08/03. doi: 10.1073/pnas.1107067108 PMID: 21808019; PubMed Central PMCID: PMC3158172.
12. Miller SE, Sahlender DA, Graham SC, Honing S, Robinson MS, Peden AA, et al. The molecular basis for the endocytosis of small R-SNAREs by the clathrin adaptor CALM. Cell. 2011; 147(5):1118-31. Epub 2011/11/29. doi: 10.1016/j.cell.2011.10.038 PMID: 22118466; PubMed Central PMCID: PMC3267021.
13. Moreau K, Fleming A, Imarisio S, Lopez Ramirez A, Mercer JL, Jimenez-Sanchez M, et al. PICALM modulates autophagy activity and tau accumulation. Nature communications. 2014; 5:4998. Epub 2014/09/23. doi: 10.1038/ncomms5998 PMID: 25241929; PubMed Central PMCID: PMC4199285.
14. Rai S, Tanaka H, Suzuki M, Ogoh H, Taniguchi Y, Morita Y, et al. Clathrin Assembly Protein CALM Plays a Critical Role in KIT Signaling by Regulating Its Cellular Transport from Early to Late Endosomes in Hematopoietic Cells. PloS one. 2014; 9(10):e109441. Epub 2014/10/04. doi: 10.1371/journal.pone. 0109441 PMID: 25279552; PubMed Central PMCID: PMC4184852.
15. Vecchi M, Polo S, Poupon V, van de Loo JW, Benmerah A, Di Fiore PP. Nucleocytoplasmic shuttling of endocytic proteins. The Journal of cell biology. 2001; 153(7):1511-7. Epub 2001/06/27. PMID: 11425879; PubMed Central PMCID: PMC2150719.
16. Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proceedings of the National Academy of Sciences of the United States of America. 1996; 93(10):4804-9. Epub 1996/05/14. PMID: 8643484; PubMed Central PMCID: PMC39360.
17. Bohlander SK, Muschinsky V, Schrader K, Siebert R, Schlegelberger B, Harder L, et al. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2000; 14(1):93-9. Epub 2000/01/19. PMID: 10637482.
18. Abdelhaleem M, Beimnet K, Kirby-Allen M, Naqvi A, Hitzler J, Shago M. High incidence of CALM-AF10 fusion and the identification of a novel fusion transcript in acute megakaryoblastic leukemia in children without Down's syndrome. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2007; 21(2):352-3. Epub 2006/12/16. doi: 10.1038/sj.leu.2404503 PMID: 17170719.
19. Conway AE, Scotland PB, Lavau CP, Wechsler DS. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis. Blood. 2013; 121(23):4758-68. Epub 2013/03/15. doi: 10. 1182/blood-2012-06-435792 PMID: 23487024; PubMed Central PMCID: PMC3674674.
20. Conway AE, Haldeman JM, Wechsler DS, Lavau CP. A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2014. Epub 2014/07/17. doi: 10.1038/leu.2014.221 PMID: 25027513.
21. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA: the journal of the American Medical Association. 2010; 303(18):1832-40. Epub 2010/05/13. doi: 10.1001/jama.2010.574 PMID: 20460622; PubMed Central PMCID: PMC2989531.
22. Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of neurology. 2010; 67(12):1473-84. Epub 2010/08/11. doi: 10.1001/archneurol.2010.201 PMID: 20697030; PubMed Central PMCID: PMC3048805.
23. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature genetics. 2009; 41(10):1088-93. Epub 2009/09/08. doi: 10.1038/ng.440 PMID: 19734902; PubMed Central PMCID: PMC2845877.
24. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, et al. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Human molecular genetics. 2010; 19(16):3295-301. Epub 2010/06/11. doi: 10. 1093/hmg/ddq221 PMID: 20534741; PubMed Central PMCID: PMC2908469.
25. Xiao Q, Gil SC, Yan P, Wang Y, Han S, Gonzales E, et al. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. The Journal of biological chemistry. 2012; 287(25):21279-89. Epub 2012/04/28. doi: 10.1074/jbc.M111.338376 PMID: 22539346; PubMed Central PMCID: PMC3375549.
26. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene therapy. 2000; 7(12):1063-6. Epub 2000/06/29. doi: 10.1038/sj.gt.3301206 PMID: 10871756.
27. Suri C, Fung BP, Tischler AS, Chikaraishi DM. Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1993; 13(3):1280-91. Epub 1993/03/01. PMID: 7680068.
28. Qi Y, Wang JK, McMillian M, Chikaraishi DM. Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1997; 17(4):1217-25. Epub 1997/02/15. PMID: 9006967.
29. Kingston RE, Chen CA, Okayama H. Calcium phosphate transfection. Current protocols in immunology / edited by John E Coligan [et al]. 2001;Chapter 10:Unit 10 3. Epub 2008/04/25. doi: 10.1002/0471142735.im1013s31 PMID: 18432676.
30. Klebig ML, Wall MD, Potter MD, Rowe EL, Carpenter DA, Rinchik EM. Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100 (14):8360-5. Epub 2003/07/02. doi: 10.1073/pnas.1432634100 PMID: 12832620; PubMed Central PMCID: PMC166234.
31. Du C, Redner RL, Cooke MP, Lavau C. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes. Blood. 1999; 94(2):793-802. Epub 1999/07/09. PMID: 10397747.
32. Lavau C, Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. The EMBO journal. 1997; 16(14):4226-37. Epub 1997/07/16. PMID: 9250666; PubMed Central PMCID: PMC1170048.
33. Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G, et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 2006; 441(7089):106-10. Epub 2006/03/31. doi: 10.1038/nature04687 PMID: 16572121.
34. Hawley RG, Lieu FH, Fong AZ, Hawley TS. Versatile retroviral vectors for potential use in gene therapy. Gene therapy. 1994; 1(2):136-8. Epub 1994/03/01. PMID: 7584069.
35. Tang X, Lucas JE, Chen JL, LaMonte G, Wu J, Wang MC, et al. Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs. Cancer research. 2012; 72(2):491-502. Epub 2011/12/03. doi: 10.1158/0008-5472.CAN-11-2076 PMID: 22135092; PubMed Central PMCID: PMC3261313.
36. Gatza ML, Kung HN, Blackwell KL, Dewhirst MW, Marks JR, Chi JT. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes. Breast cancer research: BCR. 2011; 13(3):R62. Epub 2011/06/16. doi: 10.1186/bcr2899 PMID: 21672245; PubMed Central PMCID: PMC3218951.
37. Chang JT, Nevins JR. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics. 2006; 22(23):2926-33. Epub 2006/09/27. doi: 10.1093/bioinformatics/btl483 PMID: 17000751.
38. Kelleher JK, Masterson TM. Model equations for condensation biosynthesis using stable isotopes and radioisotopes. The American journal of physiology. 1992; 262(1 Pt 1):E118-25. Epub 1992/01/01. PMID: 1733242.
39. Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG, et al. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer research. 2013; 73 (9):2850-62. Epub 2013/02/27. doi: 10.1158/0008-5472.CAN-13-0382-T PMID: 23440422; PubMed Central PMCID: PMC3919498.
40. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell metabolism. 2008; 8(6):512-21. Epub 2008/12/02. doi: 10.1016/j.cmet.2008.10.008 PMID: 19041766; PubMed Central PMCID: PMC2652870.
41. Goldstein JL, Brown MS. The LDL receptor. Arteriosclerosis, thrombosis, and vascular biology. 2009; 29(4):431-8. Epub 2009/03/21. doi: 10.1161/ATVBAHA.108.179564 PMID: 19299327; PubMed Central PMCID: PMC2740366.
42. Goedeke L, Fernandez-Hernando C. Regulation of cholesterol homeostasis. Cellular and molecular life sciences: CMLS. 2012; 69(6):915-30. Epub 2011/10/20. doi: 10.1007/s00018-011-0857-5 PMID: 22009455.
43. Anderson RG. Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology. Trends in cell biology. 2003; 13(10):534-9. Epub 2003/09/26. PMID: 14507481.
44. Simons K, Toomre D. Lipid rafts and signal transduction. Nature reviews Molecular cell biology. 2000; 1 (1):31-9. Epub 2001/06/20. doi: 10.1038/35036052 PMID: 11413487.
45. Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nature reviews Molecular cell biology. 2008; 9(2):125-38. Epub 2008/01/25. doi: 10.1038/nrm2336 PMID: 18216769.
46. Espenshade PJ, Hughes AL. Regulation of sterol synthesis in eukaryotes. Annual review of genetics. 2007; 41:401-27. Epub 2007/08/02. doi: 10.1146/annurev.genet.41.110306.130315 PMID: 17666007.
47. Chang TY, Chang CC, Ohgami N, Yamauchi Y. Cholesterol sensing, trafficking, and esterification. Annual review of cell and developmental biology. 2006; 22:129-57. Epub 2006/06/07. doi: 10.1146/annurev.cellbio.22.010305.104656 PMID: 16753029.
48. Ikonen E. Mechanisms for cellular cholesterol transport: defects and human disease. Physiological reviews. 2006; 86(4):1237-61. Epub 2006/10/04. doi: 10.1152/physrev.00022.2005 PMID: 17015489.
49. Dietschy JM, Turley SD. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. Journal of lipid research. 2004; 45 (8):1375-97. Epub 2004/07/16. doi: 10.1194/jlr.R400004-JLR200 PMID: 15254070.
50. Robinet P, Fradagrada A, Monier MN, Marchetti M, Cogny A, Moatti N, et al. Dynamin is involved in endolysosomal cholesterol delivery to the endoplasmic reticulum: role in cholesterol homeostasis. Traffic. 2006; 7(7):811-23. Epub 2006/06/22. doi: 10.1111/j.1600-0854.2006.00435.x PMID: 16787396.
51. Maurer ME, Cooper JA. The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH. Journal of cell science. 2006; 119(Pt 20):4235-46. Epub 2006/09/21. doi: 10.1242/jcs.03217 PMID: 16984970.
52. Girard E, Paul JL, Fournier N, Beaune P, Johannes L, Lamaze C, et al. The dynamin chemical inhibitor dynasore impairs cholesterol trafficking and sterol-sensitive genes transcription in human HeLa cells and macrophages. PloS one. 2011; 6(12):e29042. Epub 2011/12/30. doi: 10.1371/journal.pone. 0029042 PMID: 22205993; PubMed Central PMCID: PMC3242776.
53. Girard E, Chmiest D, Fournier N, Johannes L, Paul JL, Vedie B, et al. Rab7 is functionally required for selective cargo sorting at the early endosome. Traffic. 2014; 15(3):309-26. Epub 2013/12/18. doi: 10.1111/tra.12143 PMID: 24329906.
54. Garuti R, Jones C, Li WP, Michaely P, Herz J, Gerard RD, et al. The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits. The Journal of biological chemistry. 2005; 280(49):40996-1004. Epub 2005/09/24. doi: 10.1074/jbc.M509394200 PMID: 16179341.
55. Eden ER, Sun XM, Patel DD, Soutar AK. Adaptor protein disabled-2 modulates low density lipoprotein receptor synthesis in fibroblasts from patients with autosomal recessive hypercholesterolaemia. Human molecular genetics. 2007; 16(22):2751-9. Epub 2007/09/01. doi: 10.1093/hmg/ddm232 PMID:17761685.
56. Kanatsu K, Morohashi Y, Suzuki M, Kuroda H, Watanabe T, Tomita T, et al. Decreased CALM expression reduces Abeta42 to total Abeta ratio through clathrin-mediated endocytosis of gamma-secretase. Nature communications. 2014; 5:3386. Epub 2014/03/01. doi: 10.1038/ncomms4386 PMID:24577224.
57. Song BL, Sever N, DeBose-Boyd RA. Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Molecular cell. 2005; 19(6):829-40. Epub 2005/09/20. doi: 10.1016/j.molcel.2005.08.009 PMID: 16168377.
58. Zelcer N, Sharpe LJ, Loregger A, Kristiana I, Cook EC, Phan L, et al. The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathway. Molecular and cellular biology. 2014; 34(7):1262-70. Epub 2014/01/23. doi: 10.1128/MCB.01140-13 PMID: 24449766; PubMed Central PMCID: PMC3993563.
59. Yu L, York J, von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. The Journal of biological chemistry. 2003; 278(18):15565-70. Epub 2003/02/26. doi: 10.1074/jbc.M301311200 PMID: 12601003.
60. Peake KB, Vance JE. Defective cholesterol trafficking in Niemann-Pick C-deficient cells. FEBS letters. 2010; 584(13):2731-9. Epub 2010/04/27. doi: 10.1016/j.febslet.2010.04.047 PMID: 20416299.
61. Liscum L, Faust JR. Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts. The Journal of biological chemistry. 1987; 262(35):17002-8. Epub 1987/12/15. PMID: 3680287.
62. Moreau K, Renna M, Rubinsztein DC. Connections between SNAREs and autophagy. Trends in biochemical sciences. 2013; 38(2):57-63. Epub 2013/01/12. doi: 10.1016/j.tibs.2012.11.004 PMID: 23306003.
63. Jahn R, Scheller RH. SNAREs-engines for membrane fusion. Nature reviews Molecular cell biology. 2006; 7(9):631-43. Epub 2006/08/17. doi: 10.1038/nrm2002 PMID: 16912714.
64. Sarkar S, Maetzel D, Korolchuk VI, Jaenisch R. Restarting stalled autophagy a potential therapeutic approach for the lipid storage disorder, Niemann-Pick type C1 disease. Autophagy. 2014; 10(6):1137-40. Epub 2014/06/01. doi: 10.4161/auto.28623 PMID: 24879158; PubMed Central PMCID: PMC4091173.
65. Sobo K, Le Blanc I, Luyet PP, Fivaz M, Ferguson C, Parton RG, et al. Late endosomal cholesterol accumulation leads to impaired intra-endosomal trafficking. PloS one. 2007; 2(9):e851. Epub 2007/09/06. doi: 10.1371/journal.pone.0000851 PMID: 17786222; PubMed Central PMCID: PMC1952175.
66. Vance JE. Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS letters. 2006; 580(23):5518-24. Epub 2006/06/27. doi: 10.1016/j.febslet.2006.06.008 PMID: 16797010.
67. Sarkar S, Carroll B, Buganim Y, Maetzel D, Ng AH, Cassady JP, et al. Impaired autophagy in the lipidstorage disorder Niemann-Pick type C1 disease. Cell reports. 2013; 5(5):1302-15. Epub 2013/12/03. doi: 10.1016/j.celrep.2013.10.042 PMID: 24290752; PubMed Central PMCID: PMC3957429.
68. Xu W, Tan L, Yu JT. The Role of PICALM in Alzheimer's Disease. Molecular neurobiology. 2014. Epub 2014/09/05. doi: 10.1007/s12035-014-8878-3 PMID: 25186232.
69. Thomas RS, Lelos MJ, Good MA, Kidd EJ. Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model of Alzheimer's disease-like amyloid pathology. Biochemical and biophysical research communications. 2011; 415(4):656-61. Epub 2011/11/15. doi: 10.1016/j.bbrc.2011. 10.131 PMID: 22079091.
70. Baig S, Joseph SA, Tayler H, Abraham R, Owen MJ, Williams J, et al. Distribution and expression of picalm in Alzheimer disease. Journal of neuropathology and experimental neurology. 2010; 69 (10):1071-7. Epub 2010/09/15. doi: 10.1097/NEN.0b013e3181f52e01 PMID: 20838239; PubMed Central PMCID: PMC3017341.
71. Ando K, Brion JP, Stygelbout V, Suain V, Authelet M, Dedecker R, et al. Clathrin adaptor CALM/ PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains. Acta neuropathologica. 2013; 125(6):861-78. Epub 2013/04/17. doi: 10.1007/s00401-013-1111-z PMID: 23589030.
72. Mori T, Paris D, Town T, Rojiani AM, Sparks DL, Delledonne A, et al. Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice. Journal of neuropathology and experimental neurology. 2001; 60(8):778-85. Epub 2001/08/07. PMID: 11487052.
73. Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. Nature. 2005; 438 (7068):612-21. Epub 2005/12/02. doi: 10.1038/nature04399 PMID: 16319881.
74. Karasinska JM, Hayden MR. Cholesterol metabolism in Huntington disease. Nature reviews Neurology. 2011; 7(10):561-72. Epub 2011/09/07. doi: 10.1038/nrneurol.2011.132 PMID: 21894212.
75. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(10):5856-61. Epub 2001/04/11. doi: 10.1073/pnas.081620098 PMID: 11296263; PubMed Central PMCID:PMC33303.
76. Ehehalt R, Keller P, Haass C, Thiele C, Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. The Journal of cell biology. 2003; 160(1):113-23. Epub 2003/01/08. doi: 10.1083/jcb.200207113 PMID: 12515826; PubMed Central PMCID: PMC2172747.
77. Di Paolo G, Kim TW. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nature reviews Neuroscience. 2011; 12(5):284-96. Epub 2011/03/31. doi: 10.1038/nrn3012 PMID: 21448224; PubMed Central PMCID: PMC3321383.
78. Bjorkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arteriosclerosis, thrombosis, and vascular biology. 2004; 24(5):806-15. Epub 2004/02/07. doi: 10.1161/01.ATV.0000120374. 59826.1b PMID: 14764421.
79. Bhattacharyya R, Kovacs DM. ACAT inhibition and amyloid beta reduction. Biochimica et biophysica acta. 2010; 1801(8):960-5. Epub 2010/04/20. doi: 10.1016/j.bbalip.2010.04.003 PMID: 20398792; PubMed Central PMCID: PMC2918257.
80. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993; 261(5123):921-3. Epub 1993/08/13. PMID: 8346443.
81. Morgen K, Ramirez A, Frolich L, Tost H, Plichta MM, Kolsch H, et al. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2014; 10(5 Suppl):S269-76. Epub 2014/03/13. doi: 10.1016/j.jalz.2013.11.001 PMID: 24613704.